Figure 3.

CD44v8-10 IHC of both tumors before and after chemotherapy. Immunohistochemical analysis of a transitional liver cell tumor (TLCT) prior to chemotherapy (a), a post-chemotherapy TLCT tissue (b), an osteosarcoma biopsy tissue sample obtained prior to chemotherapy (c), and a post-chemotherapy osteosarcoma tissue (d) stained with an antibody against CD44v8-10 (Inset: higher magnification; scale bar: 10 μm).(Inset: higher magnification; scale bar: 10 μm)

Yoshida et al. BMC Cancer 2012 12:444   doi:10.1186/1471-2407-12-444
Download authors' original image